Hjem › Amyotrofisk lateralsklerose › Massachusetts › Boston
Kliniske studier for Amyotrofisk lateralsklerose i Boston, MA
19 studier for Amyotrofisk lateralsklerose søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
RAPA-501 Therapy for ALS
RekruttererFase 2/3
- Massachusetts General Hospital, Boston
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
RekruttererFase 3
- Sean M. Healey & AMG Center for ALS, Boston
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- Dana Farber Cancer Institute, Boston
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
RekruttererFase 1/2
- Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, Boston
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
Rekrutterer
- Beth Israel Deaconess Medical Center, Boston
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
RekruttererFase 2
- Zydus US010, Boston
ASSESS ALL ALS Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Massachusetts General Brigham, Boston
PREVENT ALL ALS Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Massachusetts General Brigham, Boston
Study of COYA 302 for the Treatment of ALS
RekruttererFase 2/3
- Massachusetts General Hospital, Boston
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Massachusetts General Hospital, Boston
Tofersen in Non-SOD1 ALS
RekruttererFase 2
- Massachusetts General Hospital, Boston
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Rekrutterer
- Massachusetts General Hospital, Boston
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Rekrutterer
- Massachusetts General Hospital, Boston
EIM Via the Myolex mScan as an ALS Biomarker
RekruttererObservasjonsstudie
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Rekrutterer
- Massachusetts General Hospital, Boston
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
RekruttererFase 1
- Massachusetts General Hospital, Healey & AMG Center for ALS, Boston
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
RekruttererObservasjonsstudie
- Mass General Hospital -MGH, Boston
Intermuscular Coherence as a Biomarker for ALS
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Massachusetts General Hospital, Boston
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Massachusetts General Hospital, Boston
Amyotrofisk lateralsklerose-studier i andre byer
- Philadelphia, PA14 studier
- Jacksonville, FL13 studier
- Baltimore, MD13 studier
- New York City, NY11 studier
- Chicago, IL10 studier
- San Diego, CA10 studier
- San Francisco, CA10 studier
- St. Louis, MO9 studier
- Phoenix, AZ8 studier
- Dallas, TX8 studier
- Atlanta, GA8 studier
- Washington, DC7 studier
Andre studier i Boston
- Brystkreft111 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)86 studier
- Kolorektal kreft63 studier
- Metastatisk kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.